Litigation Details for ASTRAZENECA AB v. AUROBINDO PHARMA LIMITED (D.N.J. 2016)
✉ Email this page to a colleague
ASTRAZENECA AB v. AUROBINDO PHARMA LIMITED (D.N.J. 2016)
| Docket | ⤷ Sign Up | Date Filed | 2016-07-20 |
| Court | District Court, D. New Jersey | Date Terminated | 2017-08-14 |
| Cause | 35:271 Patent Infringement | Assigned To | Mary Little Cooper |
| Jury Demand | None | Referred To | Tonianne J. Bongiovanni |
| Patents | 6,369,085; 7,411,070 | ||
| Link to Docket | External link to docket | ||
Details for ASTRAZENECA AB v. AUROBINDO PHARMA LIMITED (D.N.J. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2016-07-20 | 1 | The Patents-in-Suit 10. United States Patent No. 6,369,085 (“the ’085 patent”), entitled…covered by United States Patent Nos. 6,369,085 and 7,411,070 (collectively, the “Patents-in-suit”). … This is a civil action for patent infringement arising under the patent laws of the United States, …been and still is the owner of the ’085 patent. The ’085 patent will expire on May 25, 2018, and pediatric… 12. United States Patent No. 7,411,070 (“the ’070 patent”), entitled “Form of S- omeprazole | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
